Skip to main content
Rapid immunoassay to detect anti-EGFRviii levels to evaluate vaccine efficacy

Rapid immunoassay to detect anti-EGFRviii levels to evaluate vaccine efficacy

Value Proposition Tumor-specific molecules offer the possibility of targeted cancer therapy using monoclonal antibodies (mAbs) specifically directed against the tumor-specific molecule. However, it has proven difficult to identify tumor-specific molecules. Overexpression of EGFR in human…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us